REAP Financial Group »

Trevi Therapeutics shares owned by REAP Financial Group

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by REAP Financial Group from 13F filings

Historical chart of REAP Financial Group investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by REAP Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by REAP Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 2.0k 9.15

More positions owned by REAP Financial Group

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (GJAN)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
First Tr Exchng Traded Fd Vi Ft Vest Uq Eqt (DOCT)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FFEB)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (DSEP)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FMAY)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FJUL)
American Centy Etf Tr Intl Smcp Vlu (AVDV)

View all positions for REAP Financial Group

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics